filmov
tv
Who is NurExone Biologic?

Показать описание
Listen as Chief Executive Officer, Lior Shaltiel, PhD, introduces and shares exciting information about NurExone Biologic and explains how the company aims to reshape the world of exosome-based therapies!
hashtag#Innovation hashtag#Exosomes hashtag#RegenerativeMedicine hashtag#Exotherapy hashtag#Platform
hashtag#Innovation hashtag#Exosomes hashtag#RegenerativeMedicine hashtag#Exotherapy hashtag#Platform
Who is NurExone Biologic?
5 Reasons to Watch NurExone Biologic: Revolutionizing CNS Treatments
NurExone Biologic With CEO, Lior Shaltiel, PhD | February 13th, 2025
NurExone Biologic Inc. (TSXV:NRX) | 2025 TSX Venture 50™
NurExone Biologic- Our technology
NurExone Biologic Inc. (OTCQB: NRXBF) (TSXV: NRX)
NurExone Biologic Inc. (OTCQB: NRXBF) (TSXV: NRX)
NurExone Biologic is one of the latest new listings on the TSX Venture Exchange
Nurexone Virtual Event 2024
Nurexone November 90 Second Review
NurExone Year in Review 2024
NurExone Biologic Inc. (OTCQB: NRXBF) (TSXV: NRX)
NurExone Biologic Inc. (OTCQB: NRXBF) (TSXV: NRX)
NurExone Biologic Inc. Opens the Market Monday, July 4, 2022
EMA Grants Orphan Status to NurExone (TSXV:NRX) ExoPTEN for Spinal Cord Injury
Is NurExone (TSXV:NRX) Poised for Explosive Growth? CEO Dr. Lior Shaltiel Shares Exciting Updates
Why NurExone??
NurExone Biologic highlights plans to treat spinal paralysis
NurExone Biologic: Interview mit Dr. Lior Shaltiel (CEO) S1 E1
Revolutionizing Spinal Cord Recovery 🧬 NurExone's Breakthrough 🔑 BioTech Stocks to Watch 2025📈...
13. IIF - NurExone Biologic Inc. CEO Dr. Lior Shaltiel and Chairman Yoram Drucker
Market opening ceremony NurExone Biologic TSXV
Interview mit Dr. Lior Shaltiel, CEO & Director von NurExone Biologic Inc. (WKN A3DNSU)
Nurexone Biologic (TSXV:NRX) Named a TSX Venture 50™ Company
Комментарии